IMS srl Micronizzazioni

CDMO

Italy

https://www.imsmicron.it/

Is this your company? Claim this profile

Drug Product

Analytical & Bioanalytical Services

Company Overview

About

IMS srl Micronizzazioni is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines

Therapeutic Areas

Immunology

Rheumatology

Quick Facts

HQ:Italy

Founded:2011

Employees:2,402

Capabilities & Services

Core Capabilities

Peptide Synthesis
Small Molecule API
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Inhalation

Containment Capabilities

OEB 5 (≤1 µg/m³)

Cytotoxic / ADC Handling

Production Scales

Commercial Scale

Large Scale (Metric Ton+)

Markets Served

Asia-Pacific

Regulatory Approvals

Drug Approval BG2U1O

FDA · #APR-V4755PUD · 2021-07-01

Drug Approval ED6LUJ

EMA · #APR-68XV8Z22 · 2022-05-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

EMA GMP Certificate

European Medicines Agency

Cert #: CERT-MUQZKHQW

Issued: 2020-10-20

Expires: 2025-07-24

ISO 9001:2015

International Organization for Standardization

Cert #: CERT-F80BH42G

Issued: 2020-03-27

Expires: 2025-02-14

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-RBJP4C8A

Issued: 2020-09-01

Expires: 2025-06-20

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about IMS srl Micronizzazioni

IMS srl Micronizzazioni is headquartered in Italy.
IMS srl Micronizzazioni was founded in 2011.
IMS srl Micronizzazioni has 2,402 employees.
IMS srl Micronizzazioni's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.

Find CDMOs like IMS srl Micronizzazioni

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in Italy CDMOs in Europe Small Molecule API CDMOs Formulation Development CDMOs Inhalation CDMOs OEB 5 (≤1 µg/m³) CDMOs Cytotoxic / ADC Handling CDMOs